|
|
| Name of school: |
| Date of inspection: |
| Career-Technical program/course/room: |
| Signature of inspector: |
![]() |
Bloodborne
Pathogens Self-Inspection Checklist |
![]()
Guidelines: This checklist covers regulations issued by the U.S. Department of Labor, Occupational Safety and Health Administration (OSHA) under the general industry standard 29 CFR 1910.1030. It applies to work activities that may result in exposure to blood or other potentially infectious materials. Such activities might include students learning how to take blood tests or teachers who are trained in first aid and are required to render first aid in case of emergency. This checklist does not cover acts that result in exposure to blood or other potentially infectious materials when someone voluntarily helps others in an emergency. The regulations cited apply only to private employers and their employees, unless adopted by a State agency and applied to other groups such as public employees. A yes answer to a question indicates that this portion of the inspection complies with the OSHA or U.S. Environmental Protection Agency (EPA) standard, or with a nonregulatory recommendation. Definitions of underlined terms are provided at the end of the checklist to help you understand some of the questions.
| Please Circle | |
| Exposure Control Plan | |
been developed? [29 CFR 1910.1030(c)(1)(i), (c)(1)(ii), and (c)(2)] Note:
The exposure control plan
must include
|
Y N N/A ?? |
on request for examination or copying? [29 CFR 1910.1030(c)(1)(iii)] |
Y N N/A ?? |
updated yearly? [29 CFR 1910.1030(c)(1)(iv)] |
Y N N/A ?? |
| Engineering and Work Practice Controls | |
precautions to prevent contact with blood or other potentially infectious materials? [29 CFR 1910.1030(d)(1)] |
Y N N/A ?? |
implemented before personal protective equipment is used? [29 CFR 1910.1030(d)(2)(i)] |
Y N N/A ?? |
maintained on a regular schedule to ensure their effectiveness? [29 CFR 1910.1030(d)(2)(ii)] |
Y N N/A ?? |
[29 CFR 1910.1030(d)(2)(iii),(iv)] Note:
If providing handwashing facilities is
|
Y N N/A ?? |
immediately after removing gloves or other personal protective equipment? [29 CFR 1910.1030(d)(2)(v)] |
Y N N/A ?? |
hands or other skin areas with soap and water after contact with blood or other potentially infectious materials? [29 CFR 1910.1030(d)(2)(vi)] |
Y N N/A ?? |
Note: NIOSH recommends avoiding needle recapping. Note:
When no feasible alternatives are available, |
Y N N/A ?? |
of contaminated needles does not occur? [29 CFR 1910.1030(d)(2)(vii)] |
Y N N/A ?? |
cosmetics, and handle contact lenses in work areas where the potential exists for exposure to bloodborne pathogens? [29 CFR 1910.1030(d)(2)(ix)] |
Y N N/A ?? |
freezers, shelves, cabinets, or on countertops or benchtops where blood or other potentially infectious materials are present? [29 CFR 1910.1030(d)(2)(x)] |
Y N N/A ?? |
infectious materials performed in a way that minimizes splashing and generating droplets of these substances? [29 CFR 1910.1030(d)(2)(xi)] |
Y N N/A ?? |
or other potentially infectious agents prohibited? [29 CFR 1910.1030(d)(2)(xii)] |
Y N N/A ?? |
infectious materials placed in an appropriate container that prevents leakage during collection, handling, processing, storage, or transport? [29 CFR 1910.1030(d)(2)(xiii)] |
Y N N/A ?? |
| Personal Protective Equipment | |
gloves, gowns, laboratory coats, face shields or masks, and eye protection provided free to persons potentially exposed to bloodborne pathogens? [29 CFR 1910.1030(d)(3)(i)] |
Y N N/A ?? |
appropriate sizes readily accessible or issued to all students and employees? [29 CFR 1910.1030(d)(3)(iii)] |
Y N N/A ?? |
powderless gloves, or other similar alternatives readily accessible to those who are allergic to the gloves normally provided? [29 CFR 1910.1030(d)(3)(iii)] |
Y N N/A ?? |
replaced to maintain its effectiveness? [29 CFR 1910.1030(d)(3)(v)] |
Y N N/A ?? |
remove garments that have been penetrated by blood or other potentially infectious materials? [29 CFR 1910.1030(d)(3)(vi)] |
Y N N/A ?? |
personal protective equipment before leaving the work area? [29 CFR 1910.1030(d)(3)(vii)] |
Y N N/A ?? |
appropriately designated area or container for storage, washing, decontamination, or disposal of personal protective equipment? [29 CFR 1910.1030(d)(3)(viii)] |
Y N N/A ?? |
whenever the possibility exists of hand contact with blood or other potentially infectious materials? [29 CFR 1910.1030(d)(3)(ix)] Note:
This includes touching contaminated
|
Y N N/A ?? |
as soon as they are contaminated, torn, punctured or cannot function as a barrier? [29 CFR 1910.1030(d)(3)(ix)(A)] |
Y N N/A ?? |
(single-use) gloves? [29 CFR 1910.1030(d)(3)(ix)(B)] |
Y N N/A ?? |
only if the integrity of the glove is not compromised? [29 CFR 1910.1030(d)(3)(ix)(C)] |
Y N N/A ?? |
eye protection devices (such as goggles or glasses with solid side shields or chin-length face shields) whenever splashes or droplets of blood or other potentially infectious materials may be generated and eye, nose, or mouth contamination can be reasonably anticipated? [29 CFR 1910.1030(d)(3)(x)] |
Y N N/A ?? |
or similar outer garments worn whenever exposure to blood or other potentially infectious materials is anticipated? [29 CFR 1910.1030(d)(3)(xi)] |
Y N N/A ?? |
and schedule for cleaning of all areas and surfaces that may become contaminated with blood or other potentially infectious materials? [29 CFR 1910.1030(d)(4)(i)] |
Y N N/A ?? |
cleaned and decontaminated immediately, or as soon as feasible, after contact with blood or other potentially infectious materials? [29 CFR 1910.1030(d)(4)(ii)] |
Y N N/A ?? |
and surfaces removed and replaced as soon as feasible when they become overtly contaminated? [29 CFR 1910.1030(d)(4)(ii)(B)] Note:
Examples of protective coverings include: |
Y N N/A ?? |
pails and cans that are likely to become contaminated with blood or other potentially infectious materials inspected and decontaminated on a regular schedule? [29 CFR 1910.1030(d)(4)(ii)(C)] |
Y N N/A ?? |
pails and cans that are likely to become contaminated with blood or other potentially infectious materials cleaned and decontaminated immediately, or as soon as feasible, upon visible contamination? [29 CFR 1910.1030(d)(4)(ii)(C)] |
Y N N/A ?? |
with your hands prohibited? [29 CFR 1910.1030(d)(4)(ii)(D)] |
Y N N/A ?? |
cleaned up with mechanical means such as a brush and dust pan, tongs, or forceps? [29 CFR 1910.1030(d)(4)(ii)(D)] |
Y N N/A ?? |
or as soon as feasible into containers? [29 CFR 1910.1030(d)(4)(iii)(A)(1)] |
Y N N/A ?? |
closable, puncture resistant, leakproof on sides and bottom, and labeled with a biohazard warning label or colored red? [29 CFR 1910.1030(d)(4)(iii)(A)(1)] |
Y N N/A ?? |
easily accessible and located in the area where sharps are used or can be reasonably anticipated to be found? [29 CFR 1910.1030(d)(4)(iii)(A)(2)] |
Y N N/A ?? |
maintained upright throughout use? [29 CFR 1910.1030(d)(4)(iii)(A)(2)(i)] |
Y N N/A ?? |
replaced routinely and not allowed to overfill? [29 CFR 1910.1030(d)(4)(iii)(A)(2)(ii)] |
Y N N/A ?? |
prior to removal or replacement to prevent spillage or protrusion of contents during handling, storage, transport, or shipping? [29 CFR 1910.1030(d)(4)(iii)(A)(3)(i)] |
Y N N/A ?? |
secondary container if leakage is possible? [29 CFR 1910.1030(d)(4)(iii)(A)(3)(ii)] |
Y N N/A ?? |
with blood or other potentially infectious materials not stored or processed in a manner that requires a person to reach by hand into the containers where these sharps have been placed? [29 CFR 1910.1030(d)(4)(ii)(E)] |
Y N N/A ?? |
or cleaned manually or in any other manner which might expose a person to the risk of skin puncture? [29 CFR 1910.1030(d)(4)(iii)(A)(4)] |
Y N N/A ?? |
placed into containers which are: [29 CFR 1910.1030(d)(4)(iii)(B)(1)] and prevent leakage of fluid during handling, storage, transport or shipping? label or colored red? spillage or protrusion of contents during handling, storage, transport, or shipping? |
Y N N/A ?? |
than sharps, that have become contaminated on the outside placed into appropriate secondary containers as defined in (17) above? [29 CFR 1910.1030(d)(4)(iii)(B)(2)] |
Y N N/A ?? |
as possible with a minimum of agitation or movement? [29 CFR 1910.1030(d)(4)(iv)(A)] |
Y N N/A ?? |
other containers at the location it is used? [29 CFR 1910.1030(d)(4)(iv)(A)(1)] |
Y N N/A ?? |
in bags or containers labeled with the biohazard symbol or colored red? [29 CFR 1910.1030(d)(4)(iv)(A)(2)] |
Y N N/A ?? |
in bags or containers that will prevent soak-through and/or leakage of fluids to the exterior? [29 CFR 1910.1030(d)(4)(iv)(A)(3)] |
Y N N/A ?? |
wear protective gloves and other appropriate personal protective equipment? [29 CFR 1910.1030(d)(4)(iv)(B)] |
Y N N/A ?? |
blood or other potentially infectious materials removed immediately or as soon as possible by the user? [29 CFR 1910.1030(d)(3)(vi)] |
Y N N/A ?? |
available to all persons who are reasonably anticipated to come in contact with blood or other potentially infectious materials through the performance of their job duties? [29 CFR 1910.1030(f)(1)] |
Y N N/A ?? |
available to persons who have received the required bloodborne pathogen training? [29 CFR 1910.1030(f)(2)] |
Y N N/A ?? |
the hepatitis B vaccination series made available to persons whose job is reasonably anticipated to have contact with blood or other potentially infectious materials? [29 CFR 1910.1030(f)(2)(i)] |
Y N N/A ?? |
hepatitis B vaccination series signed a statement to that effect following the form prescribed by the OSHA standard? [29 CFR 1910.1030(f)(2)(iv)] |
Y N N/A ?? |
follow-up made available to an exposed person following a report of an exposure incident? [29 CFR 1910.1030(f)(3) and (5)] Note:
The medical evaluation and follow-up |
Y N N/A ?? |
with a biohazard warning label? [29 CFR 1910.1030(g)(1)(i)] Note:
Red bags or red containers may be |
Y N N/A ?? |
anticipated to have contact with blood or other potentially infectious materials in the course of their work or student activities provided training on bloodborne pathogens? [29 CFR 1910.1030(g)(2)] Note:
The training must include an |
Y N N/A ?? |
before or at the time of initial assignment where contact with blood or other potentially infectious materials is possible? [29 CFR 1910.1030(g)(2)(ii)(A)] |
Y N N/A ?? |
provided at least annually? [29 CFR 1910.1030(g)(2)(ii)(C)] |
Y N N/A ?? |
provided when changes are instituted that might affect exposure such as modification of tasks or procedures or adoption of new tasks or procedures? [29 CFR 1910.1030(g)(2)(v)] |
Y N N/A ?? |
appropriate in content and vocabulary to the educational level, literacy, and language of people to be trained? [29 CFR 1910.1030(g)(2)(vi)] |
Y N N/A ?? |
pathogen training knowledgeable in the subject matter? [29 CFR 1910.1030(g)(2)(viii)] |
Y N N/A ?? |
regarding hepatitis B vaccinations, examinations, medical testing, follow-up procedures, and copies of written opinions given in response to exposure incidents? [29 CFR 1910.1030(h)(1)] Note: These records are confidential. |
Y N N/A ?? |
shows the dates of the training sessions, the contents of the training session, the names and qualifications of person conducting the training, and the names of the persons attending the training sessions? [29 CFR 1910.1030(h)(2)(i)] |
Y N N/A ?? |
least 3 years? [29 CFR 1910.1030(h)(2)(ii)] |
Y N N/A ?? |
![]()
Definitions:
Bloodborne pathogens: pathogenic microorganisms that are present in human blood and cause disease in humans. These pathogens include hepatitis B virus (HBV) and human immunodeficiency virus (HIV).Engineering controls: controls that isolate or remove the bloodborne pathogens hazard from the workplace (e.g., sharps disposal containers, self-sheathing needles).Potentially infectious materials: include (a) the following human body fluids: blood, semen, vaginal secretions, cerebrospinal fluid, synovial fluid, pleural fluid, pericardial fluid, peritoneal fluid, amniotic fluid, and saliva in dental procedures; (b) any body fluid that is visibly contaminated with blood; (c) body fluids in situations in which it is difficult to differentiate between body fluids; (d) any unfixed tissue or organ (other than intact skin) from a human (living or dead); (e) HIV-containing cell or tissue cultures and organ cultures; (f) HIV- or HBV-containing culture medium or other solutions; and (g) blood, organs, or other tissues from experimental animals infected with HIV or HBV.Universal precautions: an approach to infection control whereby all human blood and certain human body fluids are treated as if they were infectious for HIV, HBV, and other bloodborne pathogens.Work practice controls: controls that reduce the likelihood of exposure by altering the manner in which a task is performed (e.g., prohibiting recapping of needles by a two-handed technique).
Comments/Corrective action:
|
|
|
|